Prostate-specific membrane antigen in breast carcinoma

Lancet

Volumn 349, Issue 9065, 1997, Pages 1601-

  Uría, José A ^b   Velasco, Gloria ^b   Santamaría, Iñigo ^b   Ferrando, Adolfo ^b   López Otín, Canos ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; RNA;

ANTIGEN EXPRESSION; ARTICLE; BRAIN; BREAST CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ENDOMETRIUM CANCER; HUMAN; HUMAN TISSUE; LUNG CANCER; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0342275182     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)61629-7     Document Type: Article

References (5)

1. Diamandis EP, Yu H. Prostate-specific antigen and lack of specificity for prostate cells. Lancet 1995; 345: 1186.
2. Murphy GP, Barren RJ, Erickson SJ, et al. Evaluation and comparison of two new prostate carcinoma markers. Int J Cancer 1996; 78: 809-18.
3. Israeli RS, Powell T, Fair WR, Heston WDW. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 1993; 53: 227-30.
4. Troyer JK, Beckett ML, Wright GL. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. In J Cancer 1995; 62: 552-58.
5. Maguire RT, Pascucci VL, M Aroli AN, Gulfo JV. Immunoscintigraphy in patients with colorectal, ovarian and prostate cancer. Cancer 1993; 72: 3453-62.